Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tumor Necrosis Factor-alpha × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Adenoviridae Infections 1

Interventions

Specimen Handling 86 Biopsy 66 Magnetic Resonance Spectroscopy 60 pembrolizumab 58 Cyclophosphamide 45 Nivolumab 34 venetoclax 28 fludarabine 27 Cetuximab 23 Fluorouracil 20 Carboplatin 20 Radiotherapy 19 Gemcitabine 19 Cisplatin 19 Bevacizumab 18 Oxaliplatin 16 Ipilimumab 16 Cytarabine 16 Azacitidine 16 Paclitaxel 15 Leucovorin 14 fludarabine phosphate 13 atezolizumab 13 X-Rays 13 Radiosurgery 13 tislelizumab 12 Temozolomide 12 Lenalidomide 12 Prednisone 11 Pemetrexed 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡